Evidence map›Paper›PMID 26481497›Full record

ArticleBulletin of mathematical biology2015

Estimating Tumor Growth Rates In Vivo.

Anne Talkington, Rick Durrett

Abstract read
In one paragraph

Article in Bulletin of mathematical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Mathematic Modeling of Tumor Growth During [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Monocytes engineered with iSNAP inhibit human B-lymphoma progression.Bioengineering & translational medicine · 2022
    Article
  19. Article
  20. Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Anne Talkington
Rick Durrett

Funding

Mathematical Models of Cancer Initiation, Progression, and Resistance to TherapyR01GM096190 · NIGMS · DUKE UNIVERSITY · PI DURRETT, RICK · 2010 to 2013
$1.4M
NIGMS NIH HHS R01 GM096190
6 · The paper itself

Abstract

In this paper, we develop methods for inferring tumor growth rates from the observation of tumor volumes at two time points. We fit power law, exponential, Gompertz, and Spratt’s generalized logistic model to five data sets. Though the data sets are small and there are biases due to the way the samples were ascertained, there is a clear sign of exponential growth for the breast and liver cancers, and a 2/3’s power law (surface growth) for the two neurological cancers.

Indexed as

Models, BiologicalBreast NeoplasmsFemaleHumansLiver NeoplasmsLogistic ModelsMathematical ConceptsNeoplasmsNervous System Neoplasms

Identifiers

PMID26481497
PMCPMC4764475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.